This is in agreement with the finding that TGF-α levels were still significantly reduced in COPD (20 (25-17) pg/ml) compared to the non-smokers (29 (39-17) pg/ml) group in the presence of GW280264 (p < 0.05). This evidence concerns the gene TGFA and chronic obstructive pulmonary disease.